Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Modifiable Comorbidities and Disability in Multiple Sclerosis.
Animal models of multiple sclerosis: the good, the bad and the bottom line.
New management algorithms in multiple sclerosis.
Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease.
Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
Biochemical and antiviral activity of MK-0518, a potent HIV integrase inhibitor
T-bet or not T-bet: Taking the last bow on the autoimmunity stage.
Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way.
Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial.
Atypical forms of optic neuritis.
Motivational interviewing may improve exercise experience for people with multiple sclerosis: A small randomized trial.
[Transorbital echography for assessment of optical nerve atrophy in demyelinating diseases: a pilot study].
Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia.
Ion Channel Modulation as a Therapeutic Approach in Multiple Sclerosis.
MR Imaging in Multiple Sclerosis: The Accuracy of 3D Double Inversion Recovery at 3 Tesla and the Potential for Single Sequence Imaging.
Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes.
Early detection of MS treatment complication may improve survival
Natalizumab adverse events are rare in patients with multiple sclerosis.
Vitamin D in MS: A vitamin for 4 seasons.
Modulation of CNS autoimmune responses by CD8(+) T cells coincides with their oligoclonal expansion.
Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression.
Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue.
Iranian family caregivers' challenges and issues in caring of multiple sclerosis patients: A descriptive explorative qualitative study.
Cerebral venous sinus thrombosis in the patient with multiple sclerosis associated with congenital antithrombin deficiency.
Aspirin and multiple sclerosis.
Pages
« first
‹ previous
…
225
226
227
228
229
230
231
232
233
…
next ›
last »